Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or EndometriosisFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Fibroid Uterus, Genital Diseases, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Skin and Connective Tissue Diseases, Urogenital Diseases, connective tissue disorder, connective tissue neoplasm, endometriosis, female reproductive system disorder, leiomyoma, myofibroma, myomatous neoplasm, neoplasmRecruitingPhase 32025-08-06NCT05862272

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Sumitomo Pharma Switzerland GmbH5

120 results · Page 1 of 5

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
AnnandaleAnnandaleUnited States1
ArlingtonArlingtonUnited States1
AtlantaAtlantaUnited States1
AtlantaAtlantaUnited States1
AuroraAuroraUnited States1
AventuraAventuraUnited States1
BaltimoreBaltimoreUnited States1
Bay CityBay CityUnited States1
BlufftonBlufftonUnited States1
BurbankBurbankUnited States1
Canoga ParkCanoga ParkUnited States1
ChandlerChandlerUnited States1
ChattanoogaChattanoogaUnited States1
ChicagoChicagoUnited States1
ChicagoChicagoUnited States1
CincinnatiCincinnatiUnited States1
ClevelandClevelandUnited States1
College ParkCollege ParkUnited States1
ColumbusColumbusUnited States1
ColumbusColumbusUnited States1
CovingtonCovingtonUnited States1
DallasDallasUnited States1
DallasDallasUnited States1
Dearborn HeightsDearborn HeightsUnited States1
DelandDeLandUnited States1